IRB Advisor – February 1, 2012
February 1, 2012
View Issues
-
Study evaluates use of "debriefing" statements
A new study looks at an intriguing strategy for improving study subjects' understanding and knowledge of clinical research. -
Best Practices Spotlight: Research program's RISE interviews avert problems
Research institutions increasingly conduct internal research site reviews or audits as a way to improve research regulatory compliance and prevent problems. -
Earlier testing of Alzheimer's drugs urged
In the fight against Alzheimer's disease dementia, researchers have long targeted beta-amyloid plaques, accumulated protein fragments in the brain that are a hallmark of the disease. The plaques are believed to contribute to the cognitive impairment associated with Alzheimer's disease. -
Alzheimer's testing less distressing than thought
As genetic testing becomes better able to pinpoint risk factors for various diseases, is there potential harm to subjects in giving them test results, particularly when there are limited treatment and prevention options? -
IRB takes on readability with staff education
Improving the readability of informed consent involves more than a one-time education of researchers or IRB staff it's a process that requires ongoing commitment. -
'Stepping up' to bridge the researcher/IRB gap
As the human research protection program at Mount Sinai Medical Center prepared for accreditation in 2010, IRB Manager Stacy Chandna says she and her colleagues knew they had a daunting task ahead. -
Compliance Corner: Update strategies after switch to electronic process
Transitioning to an electronic submission process is challenging. It also is a time when IRBs need to pay close attention to current compliance practices with an eye on updating standard operating procedures to reflect the new electronic practices and processes.